| payload |
{"created_at":"2026-04-20T14:04:30.285 {"created_at":"2026-04-20T14:04:30.285335+00:00","signal_type":"news_headline_delta","source":"news_rss","url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeU8tZ1NfcGcxTVdQV3BMUUNGc3ZObGU2UWY0clFISDZjeEtfWDg2THl3T1VFc0dLa3ZkQi1zODRMTkp0dnJoc1hqV2dxeDZqV2lsLXZvQ0x1T1lSY3c4c2pfc1JUbG9GRHJ0SWJkVFhJckpqN0NUNHk2M1d6R2RqNlFCNkNKcGZB?oc=5","value":{"fp":"183800bdd5944f80","published_at":"2026-04-20T13:35:00+00:00","source":"WSJ","source_domain":"wsj.com","source_url":"https://www.wsj.com","summary":"Exclusive | Eli Lilly Nears Deal for Cancer Biotech WSJ Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBC Eli Lilly Closes in on a $2 Billion M&A Deal. What It Means for the Stock. Barron's Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo","title":"Exclusive | Eli Lilly Nears Deal for Cancer Biotech - WSJ","url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeU8tZ1NfcGcxTVdQV3BMUUNGc3ZObGU2UWY0clFISDZjeEtfWDg2THl3T1VFc0dLa3ZkQi1zODRMTkp0dnJoc1hqV2dxeDZqV2lsLXZvQ0x1T1lSY3c4c2pfc1JUbG9GRHJ0SWJkVFhJckpqN0NUNHk2M1d6R2RqNlFCNkNKcGZB?oc=5"}}... |